Press Releases about Ensysce Biosciences Inc
Ensysce Biosciences Announces 1-for-15 Reverse Stock Split
December 03, 2024
Via ACCESSWIRE
Ensysce Biosciences Reports Third Quarter 2024 Financial Results
November 12, 2024
Via ACCESSWIRE
Ensysce Biosciences Receives Positive Nasdaq Listing Determination
November 07, 2024
Via ACCESSWIRE
Ensysce Biosciences Presenting at Upcoming Meetings
September 24, 2024
Via ACCESSWIRE
Ensysce Biosciences Submits Phase 3 Protocol to the FDA
September 19, 2024
Via ACCESSWIRE
Ensysce Biosciences Posts Video Updates from the IASP World Congress on Pain 2024
September 13, 2024
Via ACCESSWIRE
Ensysce Biosciences Receives Notice from Nasdaq
September 27, 2024
Via ACCESSWIRE
Ensysce Biosciences Announces IRB Approval for Key MPAR Study
August 27, 2024
Via ACCESSWIRE
Via ACCESSWIRE
Ensysce Biosciences Provides Mid-Year 2024 Update
July 23, 2024
Via ACCESSWIRE
Via ACCESSWIRE
Ensysce Biosciences Regains Compliance with Nasdaq
May 28, 2024
Via ACCESSWIRE
Ensysce Biosciences Receives Positive Nasdaq Listing Determination
February 27, 2024
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.